FIELD: medicine.
SUBSTANCE: object is handled by measuring the immunological values in peripheral blood of persons being tested; if observing the content of CD72+ B-lymphocytes of 7% or less, the content of lymphocytes with late activation markers HLADR of 14% or less, the concentration of serum IgA of 1.96 g/l or less, the developing psychic deadaptation at the stage of the psychic adaptation state is predicted.
EFFECT: predictable transition of the psychic adaptation state both of the early stage of the adaptation mechanism strain with no signs of exhaustion into the psychic deadaptation state with the reduced individual's adaptation capabilities, the presence of signs of the psychic exhaustion and potential pre-existing disease.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF CLINICAL COURSE OF SOMATOFORM DISORDERS | 2015 |
|
RU2578966C1 |
METHOD FOR PREDICTING PROTRACTED COURSE OF PANIC DISORDER | 2020 |
|
RU2749487C1 |
METHOD FOR PREDICTION OF CHRONIC COURSE OF NEUROTIC DISORDERS | 2009 |
|
RU2421727C1 |
METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN SCHIZOPHRENIC PATIENTS | 2014 |
|
RU2546021C1 |
METHOD FOR PREDICTION OF UNFAVOURABLE COURSE OF POSTTRAUMATIC STRESS DISORDER (PTSD) | 2009 |
|
RU2421728C1 |
METHOD OF THE PANIC DISORDER FORMING RISK PREDICTING AT THE EARLY STAGE OF DISEASE | 2016 |
|
RU2644309C1 |
METHOD FOR PREDICTING THE FLOW OF POST-TRAUMATIC STRESS DISORDERS | 2006 |
|
RU2310202C1 |
METHOD FOR PREDICTION OF RISK OF FORMATION OF ORGANIC ANXIETY DISORDER | 2019 |
|
RU2712915C1 |
METHOD FOR PREDICTING EFFECTIVENESS OF OLANZAPINE ATYPICAL ANTIPSYCHOTIC DRUG THERAPY IN SCHIZOPHRENIA PATIENTS | 2017 |
|
RU2680529C1 |
METHOD FOR PREDICTING THE FLOW OF DEPRESSIVE REACTIONS | 2003 |
|
RU2239190C1 |
Authors
Dates
2014-09-20—Published
2013-07-11—Filed